Jectofer Injection Injection

About Jectofer Injection 500 mg/10 ml

The injection Jectofer Injection contains Ferric Carboxymaltose and is made by Globe Pharmaceuticals Ltd. The doctor confirms whether this intravenous iron is suitable for a particular patient.

There are 15 brands of Ferric Carboxymaltose listed in Bangladesh. By unit price, Jectofer Injection is among the cheapest of them. The lowest listed price is Ferium Injection 500 mg/10 ml at ৳ 700 per unit.

What is Jectofer Injection 500 mg/10 ml?

Jectofer Injection is a injection from Globe Pharmaceuticals Ltd., with the generic name Ferric Carboxymaltose. Its active substance is Ferric Carboxymaltose, a complex that releases iron gradually so the body can use it to rebuild iron stores. This medicine is a parenteral iron preparation, meaning iron is delivered into the body through a vein rather than by mouth. The doctor decides whether it is suitable and how it should be given.

Uses of Jectofer Injection

The doctor confirms whether this intravenous iron is suitable for a particular patient. It is also indicated for adults with iron deficiency anaemia and non-dialysis dependent chronic kidney disease. Iron is needed to make hemoglobin, which carries oxygen around the body. Ask your doctor whether it is right for your condition.

How to use Jectofer Injection

Jectofer Injection is given by a healthcare professional into a vein; it is not for self-administration at home. Do not inject it yourself unless a doctor has shown you how. If a dose is missed, ask the doctor or pharmacist for advice. The doctor decides the dose and course based on your body weight, your iron needs and your response. The doctor decides the dose and course, taking into account body weight and other factors.

Side effects of Jectofer Injection

Tell the healthcare team straight away if you feel unwell during or after the injection. Serious allergic-type reactions, including anaphylactic reactions, have been reported. Some people may experience nausea, vomiting, headache, dizziness, flushing, itching, rash, hives, wheezing, constipation, low blood pressure or a change in taste. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.

Safety and precautions

Jectofer Injection is given only under medical supervision, and staff watch for allergic-type reactions during and after it. It is classified as Pregnancy Category C, so pregnancy and breastfeeding should be discussed with the doctor, who will weigh the potential benefits and risks. Whether it is safe while breastfeeding should be discussed with the doctor. Tell your doctor before treatment if you have had an allergic reaction to iron products or to any ingredient in this injection.

Frequently asked questions

Why is Jectofer Injection prescribed?

The doctor confirms whether this intravenous iron is suitable for a particular patient. It is also indicated for adults with iron deficiency anaemia and non-dialysis dependent chronic kidney disease.

How should I take Jectofer Injection?

Jectofer Injection is given by a healthcare professional into a vein; it is not for self-administration at home. Do not inject it yourself unless a doctor has shown you how.

What should I watch for while using Jectofer Injection?

Tell the healthcare team straight away if you feel unwell during or after the injection. Serious allergic-type reactions, including anaphylactic reactions, have been reported.

Is Jectofer Injection safe for everyone?

Jectofer Injection is given only under medical supervision, and staff watch for allergic-type reactions during and after it. It is classified as Pregnancy Category C, so pregnancy and breastfeeding should be discussed with the doctor, who will weigh the potential benefits and risks.

Indications

Ferric Carboxymaltose is indicated for the treatment of iron deficiency anemia in adult patients-
  • Who have intolerance to oral iron or have had unsatisfactory response to oral iron
  • Who have non-dialysis dependent chronic kidney disease.

Pharmacology

Non-dextran, IV is a colloidal iron hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron; replaces iron stores found in hemoglobin, myoglobin, and enzymes; works to transport oxygen via hemoglobin Macrophage engulf FCM from blood and control iron release. Transferrin saturates and, Iron into the liver, spleen and Bone marrow.

Dosage & Administration

For patients weighing 50 kg or more: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 750 mg for a total cumulative dose not to exceed 1500 mg of iron per course.

For patients weighing less than 50 kg: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 15 mg/kg body weight for a total cumulative dose not to exceed 1500 mg of iron per course.

The dosage of Ferric Carboxymaltose is expressed in mg of elemental iron. Each mL of Ferric Carboxymaltose contains 50 mg of elemental iron. Ferric Carboxymaltose treatment may be repeated if iron deficiency anemia reoccurs.

Administer Ferric Carboxymaltose intravenously, either as an undiluted slow intravenous push or by infusion. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. When administered via infusion, dilute up to 750 mg of iron in no more than 250 mL of sterile 0.9% sodium chloride injection, USP, such that the concentration of the infusion is not less than 2 mg of iron per mL and administer over at least 15 minutes.

When added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL, Ferric Carboxymaltose solution is physically and chemically stable for 72 hours when stored at room temperature. To maintain stability, do not dilute to concentrations less than 2 mg iron/mL.

Inspect parenteral drug products visually for the absence of particulate matter and discoloration prior to administration. The product contains no preservatives. Each vial of Ferric Carboxymaltose is intended for single use only. Any unused drug remaining after injection must be discarded.

Avoid extravasation of Ferric Carboxymaltose since brown discoloration of the extravasation site may be long lasting. Monitor for extravasation. If extravasation occurs, discontinue the Ferric Carboxymaltose administration at that site.

Interaction

There are no known drug interactions and none well documented.

Contraindications

Hypersensitivity to any of its components.

Side Effects

Nausea, Hypertension, Flushing, Decreased blood phosphorus, Dizziness, Vomiting, Pruritus, Rash, Urticaria, Wheezing, Injection site discoloration, Headache, Increased alanine aminotransferase), Dysgeusia, Hypotension, Constipation, Serious anaphylactic/anaphylactoid reactions

Pregnancy & Lactation

Pregnancy Category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Precautions & Warnings

Hypersensitivity Reactions: Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Ferric carboxymaltose. Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. Monitor patients for signs and symptoms of hypersensitivity during and after Ferric carboxymaltose administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Ferric carboxymaltose when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions. Other serious or severe adverse reactions potentially associated with hypersensitivity which included, but not limited to, pruritus, rash, urticaria, wheezing, or hypotension may occur.

Hypertension: 
Transient elevations in systolic blood pressure, sometimes occurring with facial flushing, dizziness, or nausea were observed. These elevations generally occurred immediately after dosing and resolved within 30 minutes. Monitor patients for signs and symptoms of hypertension following each Ferric carboxymaltose administration.

Storage Conditions

Do not store above 30°C. Do not freeze.

Alternative brands of Ferric Carboxymaltose

Other brands with the same generic name, cheapest first.

See all 15 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.